Read + Share
Shrivastava A, Singh S, Boorgula GD, Galvez R-A, et al. Ivacaftor affects the susceptibility of standard-of-care drugs used to treat
Mycobacterium abscessus lung disease. Antimicrob Agents Chemother 2025;69:e0003025.
PMID: 40372084
|
 |
|
Shrivastava A, Singh S, Boorgula GD, Galvez R-A, et al. Ivacaftor affects the susceptibility of standard-of-care drugs used to treat
Mycobacterium abscessus lung disease. Antimicrob Agents Chemother 2025;69:e0003025.
PMID: 40372084
|
|
|
|